Despite challenges, new treatments abound for AAT deficiency.
Thomas
T
Morrow
D006301:Health Services Needs and Demand; D006801:Humans; D008329:Managed Care Programs / Q000458:organization & administration; D011994:Recombinant Proteins / Q000627:therapeutic use; D000515:alpha 1-Antitrypsin / Q000627:therapeutic use*; D019896:alpha 1-Antitrypsin Deficiency / Q000175:diagnosis / Q000188:drug therapy*
D011994:Recombinant Proteins; D000515:alpha 1-Antitrypsin